Blog
USDTL Now GSA Certified Contractor
DES PLAINES, Ill. (May 25, 2012) – Des Plaines, IL,—We are pleased to announce that United States Drug Testing Laboratories, Inc. (USDTL) has been awarded a 5-year Federal Supply Schedule (FSS) contract (V797P-2097D) from the Department of Veteran Affairs as part of the General Services Administration (GSA) Multiple Award Schedule which went into effect February 15, 2012. USDTL received the award for Schedule 621II Medical Laboratory Testing and Analytical Services as a certified small business enterprise.
VA Centers around the nation can now utilize USDTL’s state-of-the-art, long-term alcohol and drug biomarkers to assist with the treatment of chronic substance abuse. The contract also allows OB/GYN practitioners at all US military hospitals access to USDTL’s state-of-the-art toxicology services for newborn meconium and umbilical cord tissue testing for prenatal exposure to substances of abuse and heavy alcohol use.
USDTL is a leader in the toxicology industry; bringing new and innovative services to market to assist healthcare professionals to solve complex addiction issues. Government purchasers may contact Client Services at (800) 235-2367 or clientservice@usdtl.com to obtain more information and to coordinate specimen collection instructions and supplies.
Contact:
Joseph Jones, Vice President of Laboratory Services
joe.jones@usdtl.com
(800) 235-2367
- Forensic vs. Clinical Drug Testing: Why Flexibility Matters for Your Organization
- USDTL’s Integration and Partnership With CourtFact
- New Year, New Capabilities: Offering Forensic & Clinical Testing Options
- Weather Delay
- The Detection of Delta-9-tetrahydrocannabinol, Delta-8-tetrahydrocannabinol, Delta-10-tetrahydrocannabinol, and Cannabidiol in Hair Specimens
- Umbilical Cord Tissue Testing for Ketamine
- Drugs of Abuse: A DEA Resource Guide (2024)
- Beyond THC and CBD: Understanding New Cannabinoids
- February 2026 (1)
- January 2026 (3)
- October 2025 (1)
- July 2025 (3)
- May 2025 (2)
- April 2025 (2)

